CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells

Journal of Experimental Medicine

Volumn 183, Issue 6, 1996, Pages 2533-2540

  Krummel, Matthew F ^a   Allison, James P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2;

ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; DOWN REGULATION; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CELL CYCLE; CELLS, CULTURED; CELLS, IMMOBILIZED; CROSS-LINKING REAGENTS; IMMUNOCONJUGATES; INTERLEUKIN-2; KINETICS; LATEX; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICROSPHERES; T-LYMPHOCYTES; TIME FACTORS;

EID: 0029899783     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.6.2533     Document Type: Article

References (31)

1. June, C.H., J.A. Bluestone, L.M. Nadler, and C.B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today. 15:321-331.
2. Allison, J.P. 1994. CD28-B7 interactions in T-cell activation. Curr. Opin. Immunol. 6:414-419.
3. Jenkins, M.K. 1994. The ups and downs of costimulation. Immunity. 1:443-446.
4. Boise, L.S., A.J. Minn, P.J. Noel, C.H. June, M.A. Accavitti, T. Lindsten, and C.B. Thompson. 1995. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity. 3:87-98.
5. Linsley, P.S. J.L. Greene, P. Tan, J. Bradshaw, J.A. Ledbetter, C. Anasetti, and N.K. Damle. 1992. Coexpression and functional cooperativity of CTLA-4 and CD28 on activated T lymphocytes. J. Exp. Med. 176:1595-1604.
6. Walunas, T.L., D.J. Lenschow, C.Y. Bakker, P.S. Linsley, G.J. Freeman, J.M. Green, C.B. Thompson, and J.A. Bluestone. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity. 1:405-413.
7. Krummel, M.F., and J.P. Allison. 1995. CD28 and CTLA-4 deliver opposing signals which regulate the response of T cells to stimulation. J. Exp. Med. 182:459-465.
8. Kearney, E.R., T.L. Walunas, R.W. Karr, P.A. Morton, D.Y. Loh, J.A. Bluestone, and M.K. Jenkins. 1995. Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J. Immunol. 155:1032-1036.
9. Krummel, M.F., T.J. Sullivan, and J.P. Allison. 1996. Superantigen responses and costimulation: CD28 and CTLA-4 have opposing effects on T cell expansion in vitro and in vivo. Int. Immunol. 8:519-523.
10. Waterhouse, P., J.M. Penninger, E. Timms, A. Wakeham, A. Shaninian, K.P. Lee, C.B. Thompson, H. Griesser, and T.W. Mak. 1995. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science (Wash. DC). 270:985-988.
11. Tivol, E.A., F. Borriello, A.N. Schweitzer, W.P. Lynch, J.A. Bluestone, and A.H. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 3:541-547.
12. Bluestone, J.A. 1995. New perspectives of CD28-B7-mediated T cell costimulation. Immunity. 2:555-559.
13. Allison, J.P., and M.F. Krummel. 1995. The yin and yang of T cell costimulation. Science (Wash. DC). 270:932-933.
14. Boise, L.H., P.J. Noel, and C.J. Thompson. 1995. CD28 and apoptosis. Curr. Opin. Immunol. 7:620-625.
15. Gribben, J.G., G.J. Freeman, V.A. Boussiotis, P. Rennert, C.L. Jellis, E. Greenfield, M. Barber, V.A. Restivo, X. Ke, G.S. Gray, and L.M. Nadler. 1995. CTLA-4 mediates antigen-specific apoptosis of human T cells. Proc. Natl. Acad. Sci. USA. 92:811-815.
16. Allison, J.P., W.L. Havran, M. Poenie, J. Kimura, L. Degraffenreid, S. Ajami, G. Duwe, A. Weiss, and R. Tsien. 1987. Expression and function of CD3 on murine thymocytes. In The T Cell Receptor, UCLA Symposia on Molecular and Cellular Biology, New Series. J. Kappler and M. Davis, editors. Alan R. Liss, Inc., New York. 33-45.
17. Gross, J.A., E. Callas, and J.P. Allison. 1992. Identification and distribution of the costimulatory receptor CD28 in the mouse. J. Immunol. 149:380-388.
18. Havran, W.L., S.C. Grell, G. Duwe, J. Kimura, A. Wilson, A.M. Kruisbeek, R.L. O'Brien, W. Born, R.E. Tigelaar, and J.P. Allison. 1989. Limited diversity of TCR γ chain expression of murine Thy-1+ dendritic epidermal cells revealed by Vγ3-specific monoclonal antibody. Proc. Natl. Acad. Sci. USA. 86:4185-4189.
19. Lane, P., W. Gerhard, S. Hubele, A. Lanzavecchia, and F. McConnell. 1994. Expression and functional properties of mouse BB1/B7 using a fusion protein between mouse CTLA-4 and human g1. Immunol. 80:56-61.
20. Ozato, K., and D.H. Sachs. 1981. Monoclonal antibodies to mouse MHC antigens. J. Immunol. 126:317-323.
21. Symington, F., and J. Sprent. 1981. A monoclonal antibody detecting an Ia specificity mapping in the I-A or I-E subregion. Immunogenetics. 14:53-61.
22. Sarmiento, M., A. Glasebrook, and F.W. Fitch. 1980. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J. Immunol. 125:2665-2672.
23. Harding, F., J.G. McArthur, J.A. Gross, D.H. Raulet, and J.P. Allison. 1992. CD28 mediated signalling costimulates murine T cells and prevents the induction of anergy in T cell clones. Nature (Lond.). 356:607-609.
24. Telford, W.G., L.E. King, and P.J. Fraker. 1992. Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry. Cytometry. 13:137-143.
25. Cerdan, C., Y. Martin, M. Courcoul, H. Brailly, C. Mawas, F. Birg, and D. Olive. 1992. Prolonged IL-2 receptor a/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28: demonstration of combined transcriptional and post-transcriptional regulation. J. Immunol. 149:2225-2229.
26. Smith, K.A., and D.A. Cantrell. 1985. Interleukin-2 regulates its own receptors. Proc. Natl. Acad. Sci. USA. 82:864-870.
27. Toyooka, K., S. Maruo, T. Iwahori, N. Yamamoto, X. Tai, R. Abe, Y. Takahama, M. Murakami, T. Uede, T. Hamaoka, and H. Fujiwara. 1996. CD28 co-stimulatory signals induce IL-2 receptor expression on antigen-stimulated virgin T cells by an IL-2 independent mechanism. Int. Immunol. 8:159-169.
28. Ziegler, S.F., F. Ramsdell, and M.R. Alderson. 1994. The activation antigen CD69. Stem Cells. 12:456-465.
29. Hathcock, K.S., G. Laszlo, C. Pucillo, P. Linsley, and R.J. Hodes. 1994. Comparative analysis of B7-1 and B7-2 costimulatory ligands: Expression and function. J. Exp. Med. 180: 631-640.
30. Inaba, K., M. Witmer-Pack, M. Inaba, K.S. Hathcock, H. Sakuta, M. Azuma, H. Yagita, K. Okumura, P.S. Linsley, S. Ikehara, et al. 1994. The tissue distribution of the B7-2 costimulator in mice: Abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med. 180:1849-1860.
31. Nagata, S., and P. Golstein. 1995. The fas death factor. Science (Wash. DC). 267:1149-1456.